IAM Market moves to the IAM platform
The global marketplace allows IP rights owners to present assets for license, sale or transfer to our unique audience of senior decision takers and deal makers
The global marketplace allows IP rights owners to present assets for license, sale or transfer to our unique audience of senior decision takers and deal makers
“In 2022 we chose to wind down our wireless patent pools. Consistent with that decision, we are also exiting the Alium partnership,” states Via LA President Heath Hoglund
Although heavy reliance on government-backed initiatives creates uncertain future for IP holders
The convergence of tech and biopharma has major implications for patent professionals
13 January 2023
A string of deals announced during December and the beginning of January send a very clear message to policymakers and regulators
12 January 2023
Sales of drug earnings streams is an increasingly popular means of monetising life sciences innovations
10 January 2023
Purchase by Sino Biopharm subsidiary has been put on hold by US authorities
04 January 2023
Chinese company also extends 2017 patent licence agreement with Nokia
23 December 2022
New contender is a large firm that does not need external financing but original buyer Catapult IP Innovations is now in final negotiations with new financial partners
21 December 2022
The agreement is one of the largest single-asset deals of all time
19 December 2022
The year’s largest acquisition sees several IP-backed rare disease treatments change hands
15 December 2022
Data platform changes at the USPTO may mean transactions are being recorded more slowly than usual, says AST
08 December 2022
Imago BioSciences buyout is intended to diversify the company’s revenue streams
28 November 2022
Unlock unlimited access to all IAM content